Business

The Economic Implications of Hyperkalemia in a Medicaid Managed Care Population

Nihar R. Desai, MD, MPH; Pamala Reed, DrPH, MPH; Paula J. Alvarez, RPh, MBA, MPH; Jeanene Fogli, PhD, RD; Steven D. Woods, PharmD; Mary Kay Owens, RPh, CPh

Stakeholder Perspective

The Impact of Quality Care on a Medicaid Population with Hyperkalemia

Byron C. Scott, MD, MBA

Business, Original Research

Realized and Projected Cost-Savings from the Introduction of Generic Imatinib Through Formulary Management in Patients with Chronic Myelogenous Leukemia

David Campbell, PharmD, MS; Marlo Blazer, PharmD, BCOP; Lisa Bloudek, PharmD, MS; John Brokars, MS; Dinara Makenbaeva, MD, MBA

Stakeholder Perspective

The Challenges in Budgeting Potential Savings with the Launch of Generic Drugs

James T. Kenney, RPh, MBA

Business, Original Research

Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States

Michael C. Runken, PharmD; Joshua M. Noone, PhD; Christopher M. Blanchette, PhD, MBA; Emily Zacherle, MS; Reuben Howden, PhD

Stakeholder Perspective

Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?

Gary M. Owens, MD

Business, Original Research

Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer

Krishna Tangirala, MPH; Sreevalsa Appukkuttan, MPH, MBBS; Stacey Simmons, MD

Business, Original Research

Clinical and Budget Impact of Increasing Colorectal Cancer Screening by Blood- and Stool-Based Testing

Joshua A. Roth, PhD, MHA; Theo deVos, PhD; Scott D. Ramsey, MD, PhD

Business, Original Research

Cost-Saving Opportunities with an Oral and Intravenous Once-Daily Aminomethylcycline Antibiotic for Hospitalized Patients with Community-Acquired Bacterial Pneumonia: Findings from Decision-Analytic Models

Thomas Lodise, PhD, PharmD; Kenneth LaPensee, PhD, MPH

Business, Original Research

Prevalence and Economic Burden of Epilepsy in the Institutionalized Medicare Fee-for-Service Population

Kathryn Fitch, RN, MEd; Xiaoyun Pan, MS, PhD; Jocelyn Lau, MPH; Tyler Engel, ASA, MAAA; Krithika Rajagopalan, MS, PhD

Business, Original Research

The Economic Value of Customized versus Off-the-Shelf Knee Implants in Medicare Fee-for-Service Beneficiaries

Mary I. O’Connor, MD; Brittany E. Blau, MPH

Business, Case Study

The Challenge of Variable Costs in Decisions Based on Cost-Effectiveness Evidence: A Case Study for Brodalumab

Diana Brixner, RPh, PhD; Gary Oderda, PharmD, MPH; Joseph Biskupiak, PhD, MBA; Douglas S. Burgoyne, PharmD, FAMCP; Steven G. Avey, RPh, MS, FAMCP; Steven R. Feldman, MD, PhD

Business, Original Research

Potential Cost-Savings with Once-Daily Aminomethylcycline Antibiotic versus Vancomycin in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

Ken LaPensee, PhD, MPH; Thomas Lodise, PharmD, PhD

Stakeholder Perspective

Love the Models, Send Me My Data: Conceptual Healthcare Decision Models Informing the Treatment of Acute Bacterial Skin and Skin Structure Infections

Michael F. Murphy, MD, PhD

Page 3 of 16
Results 21 - 30 of 153

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.